| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.25 | 0.07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.093 | 0.08 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.095 | 0.08 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |